Baxter International Inc. Files 8-K
Ticker: BAX · Form: 8-K · Filed: Nov 27, 2024 · CIK: 10456
Sentiment: neutral
Topics: corporate-filing, financials, bylaws
Related Tickers: BAX
TL;DR
BAX filed an 8-K on Nov 26, 2024, updating bylaws and filing financials. FY ends Dec 31.
AI Summary
Baxter International Inc. filed an 8-K on November 26, 2024, reporting amendments to its articles of incorporation or bylaws and filing financial statements and exhibits. The filing details the company's structure and financial reporting, with its fiscal year ending on December 31st.
Why It Matters
This filing provides an update on Baxter International's corporate structure and financial reporting, which is important for investors to understand the company's governance and financial health.
Risk Assessment
Risk Level: low — This is a routine filing detailing corporate and financial information, not indicating any immediate operational or financial distress.
Key Players & Entities
- Baxter International Inc. (company) — Registrant
- November 26, 2024 (date) — Date of earliest event reported
- December 31 (date) — Fiscal year end
FAQ
What specific amendments were made to Baxter International Inc.'s articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What financial statements and exhibits are being filed with this 8-K?
The filing states that financial statements and exhibits are being filed, but the specific list or content of these documents is not detailed in the provided text.
When is Baxter International Inc.'s fiscal year end?
Baxter International Inc.'s fiscal year ends on December 31st.
What is the Central Index Key (CIK) for Baxter International Inc.?
The CIK for Baxter International Inc. is 0000010456.
What is the Standard Industrial Classification (SIC) code for Baxter International Inc.?
The SIC code for Baxter International Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 895 words · 4 min read · ~3 pages · Grade level 15.5 · Accepted 2024-11-27 16:29:43
Key Financial Figures
- $1.00 — ange on which registered Common Stock, $1.00 par value BAX (NYSE) New York Stock Exc
Filing Documents
- bax-20241126.htm (8-K) — 34KB
- ex31.htm (EX-3.1) — 97KB
- ex31001.jpg (GRAPHIC) — 297KB
- ex31002.jpg (GRAPHIC) — 281KB
- ex31003.jpg (GRAPHIC) — 248KB
- ex31004.jpg (GRAPHIC) — 302KB
- ex31005.jpg (GRAPHIC) — 224KB
- ex31006.jpg (GRAPHIC) — 217KB
- ex31007.jpg (GRAPHIC) — 231KB
- ex31008.jpg (GRAPHIC) — 267KB
- ex31009.jpg (GRAPHIC) — 267KB
- ex31010.jpg (GRAPHIC) — 345KB
- ex31011.jpg (GRAPHIC) — 226KB
- ex31012.jpg (GRAPHIC) — 241KB
- ex31013.jpg (GRAPHIC) — 270KB
- ex31014.jpg (GRAPHIC) — 279KB
- ex31015.jpg (GRAPHIC) — 294KB
- ex31016.jpg (GRAPHIC) — 266KB
- ex31017.jpg (GRAPHIC) — 263KB
- ex31018.jpg (GRAPHIC) — 269KB
- ex31019.jpg (GRAPHIC) — 281KB
- ex31020.jpg (GRAPHIC) — 242KB
- ex31021.jpg (GRAPHIC) — 112KB
- 0001628280-24-049407.txt ( ) — 7819KB
- bax-20241126.xsd (EX-101.SCH) — 3KB
- bax-20241126_def.xml (EX-101.DEF) — 18KB
- bax-20241126_lab.xml (EX-101.LAB) — 32KB
- bax-20241126_pre.xml (EX-101.PRE) — 19KB
- bax-20241126_htm.xml (XML) — 6KB
03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On and effective as of November 26, 2024, the Board of Directors (the "Board") of Baxter International Inc. (the "Company") approved and adopted an amendment and restatement of the Amended and Restated Bylaws of the Company (as so amended and restated, the "Amended and Restated Bylaws") to, among other things: revise the default voting standard for matters other than director elections to be a majority of shares entitled to vote on the matter; require stockholders seeking to nominate directors pursuant to the universal proxy rules adopted by the U.S. Securities and Exchange Commission to comply with the requirements of those rules and provide reasonable evidence of related compliance upon request; require stockholders submitting a proposal or nomination to attend the applicable stockholders' meeting, or send a qualified representative, to present such proposal or nomination; update and enhance the procedural and disclosure requirements in connection with a stockholder's submission of a request, proposal or nomination under the Company's special meeting, advance notice or proxy access bylaw, including by (a) requiring additional background information, disclosures and representations with respect to such stockholder, any proposed nominees and certain other interested persons in the required notice; (b) reducing the deadline by which such notice must updated, if necessary, so that it remains true and correct as of the record date from ten to five business days after the record date; and (c) clarifying the procedures for submitting nominations at special meetings; revise the Company's special meeting bylaw to require a stockholder seeking to call a special meeting to continue to hold the required percentage of shares through the date of the meeting, clarify the Board's discretion in determining the date, time and format of a requested meeting and specify certain circumstances in
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 3.1 Amended and Restated Bylaws of Baxter International Inc. dated November 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 27, 2024 BAXTER INTERNATIONAL INC. By: /s/ Ellen K. Bradford Name: Ellen K. Bradford Title: Senior Vice President and Corporate Secretary